Oral

[O2-6] Viral Diversity

Mon. Nov 14, 2022 4:50 PM - 6:05 PM Room 6 (Conference Room 110)

Chair:Shuetsu Fukushi(National Institute of Infectious Diseases), Tadashi Watanabe(Department of Virology, Graduate School of Medicine, University of the Ryukyus)

+Add all to schedule

4:50 PM - 5:05 PM

[O2-6-13] Molecular Phylogeny of Mole-borne Gammaherpesviruses in Japan

*Fuka Kikuchi^1,2, Mami Oba², Ai Hayashi¹, Karen Yamada^1,5, Kae Senoo^1,5, Akio Shinohara³, Ken Maeda⁴, Hajime Kamiya¹, Motoi Suzuki¹, Tetsuya Mizutani², Satoru Arai¹ (1. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, 2. Center for Infectious Disease Epidemiology and Prevention Research, Tokyo University of Agriculture and Technology , 3. Frontier Science Research Center, University of Miyazaki, 4. Department of Veterinary Science, National Institute of Infectious Disease , 5. Tokyo University of Science)

5:05 PM - 5:20 PM

[O2-6-14] A girl case of idiopathic interstitial pneumonia that developed with adenovirus type 2 infection and was acutely exacerbated by primary HHV-7 infection

*Yoshiki Kawamura¹, Kei Kozawa¹, Tetsushi Yoshikawa¹ (1. Fujita Health University)

5:20 PM - 5:35 PM

[O2-6-15] Analysis of SARS CoV-2 variant escaped from vaccinated human serum

*Shigeyuki Itamura¹, Seiichiro Fujisaki¹, Shimasaki Noriko¹, Itsuki Hamamoto¹, Hideki Asanuma¹, Hideki Hasegawa¹ (1. National institute of Infectious Diseases)

5:35 PM - 5:50 PM

[O2-6-16] Development of SARS-CoV-2 control method using optical technology

*Ryosuke Matsuura^1,2,4,5, Chiew-Wen Lo^1,4,5,7, Ken Maeda², Junichi Somei³, Heihachiro Ochiai³, Satoshi Wada⁴, Takeharu Murakami⁴, Norihito Saito⁴, Takayo Ogawa⁴, Masaru Nakagawa⁵, Masami Takei⁵, Kyoji Hagiwara⁶, Yosuke Mori⁶, Yasunobu Matsumoto^1,7, Yoko Aida^1,2,4,7,5 (1. Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 2. Department of Veterinary Science, National Institute of Infectious Diseases, 3. Kaltech Co., Ltd., 4. Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 5. Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 6. Advintage Co., Ltd., 7. Laboratory of Global Animal Resource Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo)

5:50 PM - 6:05 PM

[O2-6-17] Triple combination of anti-SARS-CoV-2 oral drugs can inhibit the viral replication very efficiently

*Eiji Ido^1,2, Kengo Saito², Koji Onomoto³, Mitsutoshi Yoneyama^3,4, Toshibumi Taniguchi¹, Hidetoshi Igari¹, Shota Murata¹, Takayuki Ishige¹, Motoi Nishimura¹, Kazuyuki Matsushita¹, Hiroshi Shirasawa² (1. Chiba University Hospital, 2. Graduate School of Medicine, Chiba University, 3. Medical Mycology Research Center, Chiba University, 4. Research Institute of Disaster Medicine, Chiba University)

Session information